Literature DB >> 17325868

Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.

Daniel Ostro, Jeffrey Lipton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17325868     DOI： 10.1080/10428190600923157

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

Review 1.  Selecting the best frontline treatment in chronic myeloid leukemia.

Authors:  Musa Yilmaz; Yasmin Abaza; Elias Jabbour
Journal:  Curr Hematol Malig Rep       Date:  2015-06       Impact factor: 3.952

2.  Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.

Authors:  E Letsiou; A N Rizzo; S Sammani; P Naureckas; J R Jacobson; J G N Garcia; S M Dudek
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

3.  Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management.

Authors:  Kyung Won Kim; Atul B Shinagare; Katherine M Krajewski; Junhee Pyo; Sree Harsha Tirumani; Jyothi P Jagannathan; Nikhil H Ramaiya
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

Review 4.  Tyrosine Kinase Inhibitors Early in the Disease Course: Lessons From Chronic Myelogenous Leukemia.

Authors:  Musa Yilmaz; Elias Jabbour
Journal:  Semin Oncol       Date:  2015-09-24       Impact factor: 4.929
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.